In 2011, Lou Lintereur says Medtronic began “getting more serious” about commercializing automated insulin delivery technology. This process started out simply and built up to the closed-loop technologies we know today, like the MiniMed 780G. However, in order to get there, the company needed engineers with a background in control systems. Lintereur, the company’s chief engineer […]
Medtronic
Medtronic data shows reduced diabetes burdens with MiniMed 780G
Medtronic (NYSE:MDT) today announced new study results highlighting the benefits of its MiniMed 780G automated insulin delivery system. New data shows how the system addresses hyperglycemia and nighttime burden to tackle the unique burdens and challenges of diabetes. Those include managing highs and meal-time management or carb-counting. The company said its latest data also mirrors […]
Medtronic Diabetes has a new medical affairs director
Medtronic (NYSE:MDT) announced today that Dr. Goran Petrovski joined its Diabetes operating unit as medical affairs director. His role includes shaping the clinical evidence strategy and product design for Medtronic’s diabetes technology. The company also expects him to strengthen its presence in Central Europe, the Middle East and Africa. Petrovski brings more than 20 years […]
Medtronic MiniMed 780G recognized as a ‘World-Changing Idea’
Fast Company has named the Medtronic (NYSE:MDT) MiniMed 780G automated insulin delivery system among the “Best World-Changing Ideas” of 2024. The next-generation MiniMed 780G system won FDA approval just over a year ago. It uses the latest Guardian 4 technology and requires no fingersticks while in “SmartGuard” mode. The system provides meal detection technology providing […]
Medtronic, Arecor team up to develop insulin for implantable pumps
Arecor and Medtronic say they partnered to create a new type of insulin that would allow for the use of new insulin pump designs. These new insulin pumps in mind would sit under the skin, rather than on the surface of the skin. The research collaboration aims to develop a novel, high-concentration, thermostable insulin for […]
Medtronic warns on MiniMed 780G battery caps in Europe
Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe to warn of battery cap compatibility issues with the MiniMed 780G. MiniMed 780G offers automated insulin delivery to those with type 1 diabetes. It features SmartGuard technology to eliminate the need for fingersticks. Its Meal Detection Technology provides automatic adjustments and corrections to sugar levels […]
Study highlights benefits of automated insulin delivery for children in UK
A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the country with an artificial pancreas. The study aimed to assess the efficacy of […]
OM1, Medtronic partner on drug-eluting implant study
OM1 today announced positive results from its partnership with Medtronic (NYSE:MDT) evaluating the Propel corticosteroid-eluting implants. The Propel bioabsorbable implant family came to Medtronic through its acquisition of IntersectENT in 2022. OM1 and Medtronic partnered on their study to focus on healthcare resource use and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent […]
Tandem Diabetes Care taps miniaturization and automation for its latest systems
Tandem Diabetes Care EVP and Chief Strategy Officer Elizabeth Gasser didn’t exactly plan for the whirlwind past year or so. Over about two months, Tandem announced continuous glucose monitor (CGM) integration with the latest-generation technology from Dexcom and Abbott, launched its Tandem Source diabetes management platform and began the rollout of its new Mobi miniature insulin […]
Medtronic is raising the bar on outcomes with MiniMed 780G automated insulin delivery system
Not long ago, automated insulin delivery technology from Medtronic (NYSE:MDT) ranked third in the market in terms of patient satisfaction. That’s according to the Diabetes Patient Voice survey (DQ&A) — a third-party survey that evaluates U.S. diabetes patient satisfaction on a quarterly basis. However, things are now looking up for the world’s largest medtech company […]
